Mycophenolate Mofetil in Myasthenia Gravis

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

March 31, 2007

Conditions
Myasthenia Gravis
Interventions
DRUG

mycophenolate mofetil

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

lead

FDA Office of Orphan Products Development

FED